Founded in 2006 CTI Life Sciences Fund is a venture capital investment firm that is headquartered in Montreal, Canada. The firm prefers to invest in the life sciences and healthcare companies at the pre-clinical and clinical development stages located in the United States and Canada.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
VectivBio | 15-Oct-2020 | Later Stage VC | 00000 | Drug Discovery | Clinical Trials - Phase 3 | |
0000 000000000000 | 08-Jun-2020 | 00000 00000 | Drug Discovery | Generating Revenue | 00000000 0000000 00.0 | |
00000000 00 | 08-Jun-2020 | 0000 00000 | 000 | Discovery Tools (Healthcare) | Generating Revenue | 000000000 000000 00.0 |
0000000 | 26-Mar-2020 | 00000 00000 | 00000 | Drug Discovery | Startup | |
0000000 | 19-May-2018 | 00000 00000 | 0000 | Drug Discovery | Startup | |
00000000 | 05-Oct-2017 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | |
0000000000 | 27-Jul-2017 | 00000 00000 | 0000 | Biotechnology | Startup | 00000000 0000000 00.0 |
00000 0000000 | 27-Jun-2017 | 00000 00000 | 0000 | Network Management Software | Generating Revenue | 000000000 000000 00.0 |
Vaxcyte | 21-Mar-2017 | Later Stage VC | 0000 | Drug Discovery | Startup | |
CellAegis Devices | 10-Mar-2017 | Later Stage VC | 00.00 | Therapeutic Devices | Bankruptcy: Liquidation | 000000000 000000 00.0 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
VectivBio | 09-Apr-2021 | IPO | 00000 |
00000 00000000000 | 30-Dec-2020 | 000000000000000000 | |
00000000 0000000 | 21-Jul-2020 | 000000 0000000000 | 000.00 |
0000000 | 12-Jun-2020 | 000 | 00000 |
000000000 0000000 | 01-Jan-2020 | 0000000000: 000000 | |
000000000 | 09-Oct-2018 | 000000000000000000 | |
00000000 | 31-Aug-2018 | 000000000000000000 | 00000 |
00000 000000000000 | 01-Mar-2018 | 000 00 00000000 | |
Xagenic | 25-Jan-2018 | Merger/Acquisition | |
Xagenic | 28-Sep-2017 | Bankruptcy: Admin/Reorg |
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialName | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Mark Chadakhtzian | Chief Financial Officer & Chief Compliance Officer | Montreal, Canada | |||
Jean-Francois Leprince | Managing Partner | 0 | 0 | 0 | Montreal, Canada |
Shermaine Tilley Ph.D | Managing Partner | 00 | 0 | 0 | Montreal, Canada |
Youssef Bennani Ph.D | Managing Partner | 0 | Montreal, Canada | ||
Laurence Rulleau Ph.D | Managing Partner Fund II & III | 0 | 0 | 0 | Montreal, Canada |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Abingworth Management | 1 | 0 |
![]() |
![]() |
|
Citadel (Hedge Fund) | 0 |
![]() |
![]() |
||
Frazier Healthcare Partners | 0 | 0 |
![]() |
![]() |
|
Novo Holdings | 0 | 0 |
![]() |
![]() |
|
TPG | 0 |
![]() |
![]() |